海外の治験の状況「1」での検索結果
2657件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Recruiting
- The effect of weight stigma and the polycystic ovary syndrome (PCOS) disease label and causal explanations on intention to eat healthier and perceived personal control over weight: A randomised online study in reproductive aged women
- Polycystic Ovary Syndrome;Overweight/obesity; Polycystic Ovary Syndrome br>Overweight/obesity;Reproductive Health and Childbirth - Other reproductive health and childbirth disorders;Diet and Nutrition - Obesity;Renal and Urogenital - Other renal and urogenital disorders;Metabolic and Endocrine - Other endocrine disorders
- Australia
- 2019-06-27
Not Recruiting
- Bio-distribution evaluations of MUC-1 specific targeted immune-radiotherapy for advanced pancreatic adenocarcinoma: a first pilot human study.
- Pancreatic Cancer; Pancreatic Cancer;Cancer - Pancreatic
- Australia
- 2019-07-18
Not Recruiting
- Effects of Periodic Transcranial Direct Current Stimulation in the Management of Individuals with Fibromyalgia Syndrome: Design of a Randomized Clinical Trial with 1 Year Follow-up
- Musculoskeletal Diseases;Musculoskeletal Diseases
- Nigeria
- 2019-08-08
Not recruiting
- A Combination Efficacy Study in Africa of Two DNA-MVA-Env Protein or DNA-Env Protein HIV-1 Vaccine Regimens With PrEP
- HIV Infections
- Uganda
- 2019-08-08
Not Recruiting
- ATOMIC Ears: A Phase IIB randomised controlled trial to assess safety, tolerability and acceptability of a 5-day Dornase alfa treatment as an adjunct therapy to ventilation tube insertion for otitis media in children
- Recurrent acute otitis media;Chronic otitis media with effusion ("glue ear"); Recurrent acute otitis media Chronic otitis media with effusion ("glue ear");Ear - Other ear disorders
- Australia
- 2019-09-25
Not recruiting
- Axillary Reverse Mapping Using Methylene Blue Subcutaneous Injection Can Identify Arm Lymph Nodes and Vessels, Measuring Arm Size for Lymphedema, Histopathological Examination of Arm Lymph Nodes Included With Axillary Lymph Node Dissection
- Arm Lymphedema;Lymphatic Spread of Breast Cancer;Early Breast Cancer
- Egypt
- 2019-10-21
Authorised
- Pembrolizumab in Subjects with Advanced Recurrent Ovarian Cancer
- A:platinum-resistant or partially platinum-sensitive recurrent ovarian cancer (OC) who received 1 but no more than 3 prior lines of anticancer regimens/local standard following primary or interval debulking surgery with a platinum free interval or treatment-free interval of 3-12 months based on last regimen received B:recurrent OC who received 3-5 prior lines of anticancer regimens/local standard with a platinum-free interval or treatment-free interval >or=3months based on last regimen received MedDRA version: 18.1 Level: PT Classification code 10033128 Term: Ovarian cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Canada, Finland, France, Germany, Israel, Japan, Lithuania, Netherlands, Russian Federation, South Africa, Spain, Sweden, United States
- 2015-12-16
Not recruiting
- A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal Insulin
- Diabetes;Diabetes Mellitus, Type 2;Diabetes;Diabetes Mellitus, Type 2;Diabetes;Diabetes Mellitus, Type 2;Diabetes;Diabetes Mellitus, Type 2
- Argentina, Brazil, Croatia, Egypt, Germany, Greece, Hungary, India, Israel, Italy, Korea, Republic of, Lebanon, Malaysia, Mexico, Morocco, Poland, Portugal, Russian Federation, Serbia, South Africa, Spain, Taiwan, Turkey, United States
- 2014-05-02
Not Recruiting
- A STUDY OF THE MAINTENANCE OF EFFICACY OF ETANERCEPT PLUS DMARD(S) COMPARED WITH DMARD(S) ALONE IN SUBJECTS WITH RHEUMATOID ARTHRITIS AFTER ACHIEVING AN ADEQUATE RESPONSE WITH ETANERCEPT PLUS DMARD(S)
- Rheumatoid Arthritis MedDRA version: 14.1 Level: PT Classification code 10039073 Term: Rheumatoid arthritis System Organ Class: 10028395 - Musculoskeletal and connective tissue disorders ;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
- Argentina, Brazil, China, Colombia, Czech Republic, Egypt, Hungary, India, Malaysia, Mexico, Philippines, Poland, Romania, Russian Federation, Saudi Arabia, Slovakia, South Africa, Taiwan, Thailand, Turkey, Ukraine, United Arab Emirates
- 2012-03-21
Recruiting
- Study of Pemetrexed + Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With Tyrosine Kinase Inhibitor- (TKI)-Resistant Epidermal Growth Factor Receptor- (EGFR)-Mutated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-789/KEYNOTE-789)
- Non-small Cell Lung Cancer
- Australia, Brazil, Canada, China, France, Germany, Hong Kong, Israel, Italy, Japan, Korea, Republic of, Mexico, Spain, Sweden, Taiwan, United Kingdom, United States
- 2018-04-23
Authorised
- A phase III multi-center, open label, randomised study of optimised imatinib versus nilotinib in adult patients with newly diagnosed Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia in chronic phase (CML-CP)
- Adult patients with newly diagnosed Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia in chronic phase (CML-CP) MedDRA version: 19.0 Level: LLT Classification code 10009015 Term: Chronic myeloid leukemia System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 19.0 Level: PT Classification code 10009013 Term: Chronic myeloid leukaemia System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Austria, Belgium, Brazil, Canada, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Mexico, Netherlands, Norway, Poland, Portugal, Russian Federation, Singapore, Slovakia, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, United Kingdom, United States, Venezuela, Bolivarian Republic of
- 2007-03-14
Not Recruiting
- A clincal trial to study the effects of Bosutinib (SKI-606) compared with Imatinib in patients newly diagnosed with philadelphia chromosome positive chronic myelogenous leukemia (CML).
- Chronic Myelogenous Leukemia
- Argentina, Belgium, Brazil, Canada, Chile, China, Colombia, France, Germany, Hong Kong, Hungary, India, Italy, Japan, Latvia, Lithuania, Mexico, Poland, Republic of Korea, Russian Federation, Singapore, Slovenia, South Africa, Spain, Taiwan, Thailand, Turkey, Ukraine, United Kingdom, United States of America
- 2009-08-07
Not recruiting
- A Pilot Study of a Steroid Sulphatase Inhibitor (BN83495) in Patients Receiving an Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI) for the Treatment of Non-Small Cell Lung Cancer (NSCLC)
- Non-Small Cell Lung Cancer;Skin Rash
- Australia
- 2010-12-06
Not recruiting
- Reduction of Low-Density Lipoprotein Cholesterol (LDL-C) With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study
- Hypercholesterolemia, Familial
- Canada, Germany, Hong Kong, Netherlands, Norway, Singapore, South Africa, Spain, Sweden, United Kingdom, United States
- 2011-06-16
Not recruiting
- Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
- Chronic Myeloid Leukemia;Leukemia, Lymphoblastic, Acute, Philadelphia-positive
- Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Denmark, Finland, France, Germany, Hungary, Ireland, Israel, Italy, Korea, Republic of, Netherlands, Norway, Peru, Philippines, Poland, Russian Federation, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, United Kingdom, United States
- 2005-01-12
Authorised
- A phase III multi-center, open label, randomised study of imatinib versus nilotinib in adult patients with newly diagnosed Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia in chronic phase (CML-CP)
- Adult patients with newly diagnosed Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia in chronic phase (CML-CP) MedDRA version: 20.0 Level: LLT Classification code 10009015 Term: Chronic myeloid leukemia System Organ Class: 100000013009 MedDRA version: 20.0 Level: PT Classification code 10009013 Term: Chronic myeloid leukaemia System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Austria, Belgium, Brazil, Canada, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Mexico, Netherlands, Norway, Poland, Portugal, Russian Federation, Singapore, Slovakia, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, United Kingdom, United States, Venezuela, Bolivarian Republic of
- 2007-03-13
Recruiting
- Measurement and evaluation of thiamine concentrations in the blood of Australians who have a history of Diagnostic and Statistical Manual Fourth Edition(DSM IV) alcohol dependence or abuse, after 20 years of supplementing flour with thiamine.
- Wernicke-Korsakoff syndrome;Alcohol Dependence;Thiamine Deficiency;Alcohol Abuse
- Australia
- 2010-08-13
Not recruiting
- A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
- Diabetes;Diabetes Mellitus, Type 2;Diabetes;Diabetes Mellitus, Type 2;Diabetes;Diabetes Mellitus, Type 2
- Algeria, Austria, France, Norway, United States
- 2012-10-22
Not Recruiting
- Pre-Operative Programmed Death-1 (PD1) Checkpoint Blockade and Receptor Activator of NFkB Ligand (RANKL) Inhibition in Non-Small Cell Lung Cancer (NSCLC) (POPCORN) - a trial for patients with resectable NSCLC
- Non-small cell lung cancer (NSCLC); Non-small cell lung cancer (NSCLC);Cancer - Lung - Non small cell
- Australia
- 2018-07-06
Not Recruiting
- A clinical trial to study the effects of two drugs, iGlarLixi versus premixed insulin in patients with type 2 diabetes mellitus whose diabetes condition is uncontrolled with basal insulin and oral anti-diabetic agents.
- Type 2 diabetes mellitus without complications
- Algeria, Argentina, Austria, Bulgaria, Czech Republic, Greece, India, Kuwait, Mexico, Republic of Korea, Romania, Saudi Arabia, Serbia, Spain, Sweden, Taiwan, The former Yugoslav Republic of Macedonia, Turkey, United Arab Emirates
- 2019-03-13